Vice President of Bioservices, at Cell Culture Company
Scott supervises all operations of Biovest’s Contract Manufacturing Division and mAbVault. He also oversees upstream production at Biovest’s Biologics Manufacturing Division, which supports the manufacturing of Dasiprotimut-T, an autologous adaptive immunotherapy vaccine targeting Indolent Follicular non-Hodgkins Lymphoma. Scott holds a B.S. in Medical Technology (ASCP) from the University of Wisconsin and has been with Biovest since 1989.